Clinical Trials Market Size, Share, Trends, Growth, Consumption, Revenue, Company Analysis and Forecast 2021-2030

Published Date : Feb 2021 | No. of Pages : 250 Pages | Category : Healthcare


Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Clinical Trials Market, By Phase

7.1.  Clinical Trials Market, By Phase Type, 2020-2030

7.1.1.    Phase I

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Phase II

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Phase III

7.1.3.1.        Market Revenue and Forecast (2016-2030)

7.1.4.    Phase IV

7.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Clinical Trials Market, By Study Design

8.1.  Clinical Trials Market, By Study Design, 2020-2030

8.1.1.    Interventional

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Observational

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Expanded Access

8.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Clinical Trials Market, By Indication

9.1.  Clinical Trials Market, By Indication, 2020-2030

9.1.1.    Autoimmune/Inflammation

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Pain management

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Cardiovascular

9.1.3.1.        Market Revenue and Forecast (2016-2030)

9.1.4.    CNS condition

9.1.4.1.        Market Revenue and Forecast (2016-2030)

9.1.5.    Oncology

9.1.5.1.        Market Revenue and Forecast (2016-2030)

9.1.6.    Diabetes

9.1.6.1.        Market Revenue and Forecast (2016-2030)

9.1.7.    Obesity

9.1.7.1.        Market Revenue and Forecast (2016-2030)

9.1.8.    Others

9.1.8.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Clinical Trials Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, By Phase (2016-2030)

10.1.2.  Market Revenue and Forecast, By Study Design (2016-2030)

10.1.3.  Market Revenue and Forecast, By Indication (2016-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, By Phase (2016-2030)

10.1.4.2.      Market Revenue and Forecast, By Study Design (2016-2030)

10.1.4.3.      Market Revenue and Forecast, By Indication (2016-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, By Phase (2016-2030)

10.1.5.2.      Market Revenue and Forecast, By Study Design (2016-2030)

10.1.5.3.      Market Revenue and Forecast, By Indication (2016-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, By Phase (2016-2030)

10.2.2.  Market Revenue and Forecast, By Study Design (2016-2030)

10.2.3.  Market Revenue and Forecast, By Indication (2016-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, By Phase (2016-2030)

10.2.4.2.      Market Revenue and Forecast, By Study Design (2016-2030)

10.2.4.3.      Market Revenue and Forecast, By Indication (2016-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, By Phase (2016-2030)

10.2.5.2.      Market Revenue and Forecast, By Study Design (2016-2030)

10.2.5.3.      Market Revenue and Forecast, By Indication (2016-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, By Phase (2016-2030)

10.2.6.2.      Market Revenue and Forecast, By Study Design (2016-2030)

10.2.6.3.      Market Revenue and Forecast, By Indication (2016-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, By Phase (2016-2030)

10.2.7.2.      Market Revenue and Forecast, By Study Design (2016-2030)

10.2.7.3.      Market Revenue and Forecast, By Indication (2016-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, By Phase (2016-2030)

10.3.2.  Market Revenue and Forecast, By Study Design (2016-2030)

10.3.3.  Market Revenue and Forecast, By Indication (2016-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, By Phase (2016-2030)

10.3.4.2.      Market Revenue and Forecast, By Study Design (2016-2030)

10.3.4.3.      Market Revenue and Forecast, By Indication (2016-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, By Phase (2016-2030)

10.3.5.2.      Market Revenue and Forecast, By Study Design (2016-2030)

10.3.5.3.      Market Revenue and Forecast, By Indication (2016-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, By Phase (2016-2030)

10.3.6.2.      Market Revenue and Forecast, By Study Design (2016-2030)

10.3.6.3.      Market Revenue and Forecast, By Indication (2016-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, By Phase (2016-2030)

10.3.7.2.      Market Revenue and Forecast, By Study Design (2016-2030)

10.3.7.3.      Market Revenue and Forecast, By Indication (2016-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, By Phase (2016-2030)

10.4.2.  Market Revenue and Forecast, By Study Design (2016-2030)

10.4.3.  Market Revenue and Forecast, By Indication (2016-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, By Phase (2016-2030)

10.4.4.2.      Market Revenue and Forecast, By Study Design (2016-2030)

10.4.4.3.      Market Revenue and Forecast, By Indication (2016-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, By Phase (2016-2030)

10.4.5.2.      Market Revenue and Forecast, By Study Design (2016-2030)

10.4.5.3.      Market Revenue and Forecast, By Indication (2016-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, By Phase (2016-2030)

10.4.6.2.      Market Revenue and Forecast, By Study Design (2016-2030)

10.4.6.3.      Market Revenue and Forecast, By Indication (2016-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, By Phase (2016-2030)

10.4.7.2.      Market Revenue and Forecast, By Study Design (2016-2030)

10.4.7.3.      Market Revenue and Forecast, By Indication (2016-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, By Phase (2016-2030)

10.5.2.  Market Revenue and Forecast, By Study Design (2016-2030)

10.5.3.  Market Revenue and Forecast, By Indication (2016-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, By Phase (2016-2030)

10.5.4.2.      Market Revenue and Forecast, By Study Design (2016-2030)

10.5.4.3.      Market Revenue and Forecast, By Indication (2016-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, By Phase (2016-2030)

10.5.5.2.      Market Revenue and Forecast, By Study Design (2016-2030)

10.5.5.3.      Market Revenue and Forecast, By Indication (2016-2030)

Chapter 11.  Company Profiles

11.1.              ICON Plc

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Wuxi AppTec

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              PRA Health Sciences

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              SGS SA

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Syneos Health

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              Eli Lilly and Company

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Novo Nordisk A/S

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Pfizer

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              Clinipace

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

Glossary of Terms

Featured Research Reports

  • Featured Research Reports

    Packaging Primers Market (By Primer: Water-based Coatings, Solvent-based Coatings, and Coatings; By Application: Film Makers (Pre-converting Step), Aluminum Makers (Pre-converting Step), Paper Makers & Coaters (Pre-converting Step), and Film, Aluminum & Paper Converting (Converting Step = Lamination) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

    Read more...
  • Featured Research Reports

    Hyperthermia Cancer Treatment Market (By Device Type: Infrared Hyperthermia Devices, Ultrasound Hyperthermia Devices, Microwave Hyperthermia Devices, Others; By Application: Breast Cancer, Liver Cancer, Soft Tissue Sarcoma, Head & Neck Tumors, Prostate Cancer, Others; By Treatment Method; By End User) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

    Read more...
  • Featured Research Reports

    Intramedullary Nails Market (By Type: Long Gamma Nail [LGN], Trochanteric Femoral Nail [TFN], Intertroch/Subtroch Nail [ITST], Others; By Material: Titanium and Stainless Steel; By Application: Femoral Fracture, Tibial Fracture, Others; By End User) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

    Read more...
  • Featured Research Reports

    Multiplex Detection Immunoassays Market (By Assay Type: Planar Assay, Bead-based Assay; By Technique: Nucleic Acid-based Techniques, Protein-based Techniques, Biosensor-based Techniques; By Application: Disease Testing, Food Contamination Testing, R&D, Veterinary Disease Testing; By End User) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

    Read more...
  • Featured Research Reports

    Nucleic Acid Extraction Instruments and Reagents Market (By Type: Instruments, and Extraction Kits, Reagents, Consumables; By Extraction Type: DNA Extraction, RNA Extraction, and DNA/RNA Extraction; Method: Solution-based Methods and Solid-phase-based Methods; By End User) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

    Read more...